Chinese researchers find neutralizing antibody against COVID-19 variants
BEIJING - Chinese researchers have found a neutralizing antibody that could provide protection against the Delta and Omicron variants of COVID-19, and it has shown preventative efficacy by nasal delivery.
The antibody 58G6 detected in a COVID-19 patient was isolated and showed potent neutralizing activity inhibiting the variants, according to the study published in the journal Signal Transduction and Targeted Therapy.
It was jointly discovered by researchers from the Chongqing Medical University and the Wuhan Institute of Virology under the Chinese Academy of Sciences.
The researchers administered the antibody to hamsters via nasal delivery and found that a very low dosage of 2 milligrams per kilogram effectively prevented them from being infected with the variants, according to the paper.
It said that the antibody is expected to be used in nebulized therapy.
- Shenzhou XVIII successfully launched
- The Shenzhou XVIII spaceship successfully launched
- Xi calls on Chongqing to write its chapter in Chinese modernization
- Shandong produce seller begs for order cancellations after pricing error
- Zhejiang woman receives lenient sentence for rooftop poppy plantation
- Lucky mistake: Lottery player wins jackpot thanks to salesperson's error